Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nora Therapeutics Inc.

www.noratherapeutics.com

Latest From Nora Therapeutics Inc.

Nora Therapeutics Is Hoping To Teach An Old Dog New Tricks In Fertility

Having raised an $18 million Series B, Nora is continuing a Phase II trial of lead G-CSF candidate NT100 in IVF failure. But the biotech also has begun enrolling a second Phase II study in women with unexplained recurrent miscarriage.

BioPharmaceutical

Life Science Start-Ups: Venture Funding, May 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2014.

BioPharmaceutical Medical Device

Nora Therapeutics Is Hoping To Teach An Old Dog New Tricks In Fertility

Having raised an $18 million Series B, Nora is continuing a Phase II trial of lead G-CSF candidate NT100 in IVF failure. But the biotech also has begun enrolling a second Phase II study in women with unexplained recurrent miscarriage.

BioPharmaceutical United States

Recent Financings of Private Companies (11/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Nora Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nora Therapeutics Inc.
  • Senior Management
  • Jeffrey K Tong, PhD, Pres. & CEO
    Darryl L Carter, MD, VP, Research
    Mark P Joing, VP, Clinical Operations & Project Mgmt.
    Paul S Kwon, MD, CMO
    Vera Wolowodiuk, PhD, VP, Product Dev.
    Sandra Shpilberg, VP, Strategic Mktg. & Commercial Planning
  • Contact Info
  • Nora Therapeutics Inc.
    Phone: (443) 378-7236
    530 Lytton Ave.
    2nd Floor
    Palo Alto, CA, , CA 94301
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register